Trial Profile
Phase III trial of NM-108 in patients with diabetic macular oedema
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs NM 108 (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 15 Jun 2015 New trial record